165 related articles for article (PubMed ID: 15805849)
1. Celiac disease as a model of gastrointestinal inflammation.
Sollid LM
J Pediatr Gastroenterol Nutr; 2005 Apr; 40 Suppl 1():S41-2. PubMed ID: 15805849
[No Abstract] [Full Text] [Related]
2. Antigen presentation in celiac disease.
Qiao SW; Sollid LM; Blumberg RS
Curr Opin Immunol; 2009 Feb; 21(1):111-7. PubMed ID: 19342211
[TBL] [Abstract][Full Text] [Related]
3. Gluten in infants and celiac disease risk.
Andrén Aronsson C; Kurppa K; Agardh D
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):669-70. PubMed ID: 27027529
[No Abstract] [Full Text] [Related]
4. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
5. Celiac disease and autoimmunity.
Troncone R; Discepolo V
J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S9-S11. PubMed ID: 24979198
[TBL] [Abstract][Full Text] [Related]
6. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
Koning F; Gilissen L; Wijmenga C
Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 dysfunctions in the development of autoimmune disorders: celiac disease and TG2-/- mouse.
Szondy Z; Korponay-Szabó I; Király R; Fésüs L
Adv Enzymol Relat Areas Mol Biol; 2011; 78():295-345. PubMed ID: 22220477
[No Abstract] [Full Text] [Related]
9. Tissue transglutaminase and celiac disease.
Esposito C; Caputo I; Auricchio S; Troncone R
Prog Exp Tumor Res; 2005; 38():158-73. PubMed ID: 15746535
[No Abstract] [Full Text] [Related]
10. Evidence That Pathogenic Transglutaminase 2 in Celiac Disease Derives From Enterocytes.
Iversen R; Amundsen SF; Kleppa L; du Pré MF; Stamnaes J; Sollid LM
Gastroenterology; 2020 Aug; 159(2):788-790. PubMed ID: 32302613
[No Abstract] [Full Text] [Related]
11. A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies.
Quaglia S; Ferrara F; De Leo L; Ziberna F; Vatta S; Marchiò S; Sblattero D; Ventura A; Not T
J Immunol; 2019 Feb; 202(4):1079-1087. PubMed ID: 30635394
[TBL] [Abstract][Full Text] [Related]
12. [Disease mechanisms in coeliac disease].
Sollid LM; Lundin KE
Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3230-3. PubMed ID: 14714017
[TBL] [Abstract][Full Text] [Related]
13. Gluten-dependent intestinal autoimmune response.
Korponay-Szabó IR; Simon-Vecsei Z; De Leo L; Not T
Curr Pharm Des; 2012; 18(35):5753-8. PubMed ID: 22726113
[TBL] [Abstract][Full Text] [Related]
14. Coeliac disease: dissecting a complex inflammatory disorder.
Sollid LM
Nat Rev Immunol; 2002 Sep; 2(9):647-55. PubMed ID: 12209133
[TBL] [Abstract][Full Text] [Related]
15. Identification of Non-HLA Genes Associated with Celiac Disease and Country-Specific Differences in a Large, International Pediatric Cohort.
Sharma A; Liu X; Hadley D; Hagopian W; Liu E; Chen WM; Onengut-Gumuscu S; Simell V; Rewers M; Ziegler AG; Lernmark Å; Simell O; Toppari J; Krischer JP; Akolkar B; Rich SS; Agardh D; She JX;
PLoS One; 2016; 11(3):e0152476. PubMed ID: 27015091
[TBL] [Abstract][Full Text] [Related]
16. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
[TBL] [Abstract][Full Text] [Related]
17. Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.
Montenegro L; Piscitelli D; Giorgio F; Covelli C; Fiore MG; Losurdo G; Iannone A; Ierardi E; Di Leo A; Principi M
World J Gastroenterol; 2014 Dec; 20(46):17686-9. PubMed ID: 25516687
[TBL] [Abstract][Full Text] [Related]
18. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
[TBL] [Abstract][Full Text] [Related]
19. Introduction of gluten, HLA status, and the risk of celiac disease in children.
Lionetti E; Castellaneta S; Francavilla R; Pulvirenti A; Tonutti E; Amarri S; Barbato M; Barbera C; Barera G; Bellantoni A; Castellano E; Guariso G; Limongelli MG; Pellegrino S; Polloni C; Ughi C; Zuin G; Fasano A; Catassi C;
N Engl J Med; 2014 Oct; 371(14):1295-303. PubMed ID: 25271602
[TBL] [Abstract][Full Text] [Related]
20. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa.
Paparo F; Petrone E; Tosco A; Maglio M; Borrelli M; Salvati VM; Miele E; Greco L; Auricchio S; Troncone R
Am J Gastroenterol; 2005 Oct; 100(10):2294-8. PubMed ID: 16181383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
